medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 6

Next >>

Rev Mex Pediatr 2015; 82 (6)

Frequency of risk factors in patients with bronchopulmonary dysplasia

Maya-Barrios JA, Perdigón-Lagunes J, Torres-Narváez P, Hernández-Delgado L, Jiménez-Escobar I
Full text How to cite this article

Language: Spanish
References: 16
Page: 192-96
PDF size: 255.27 Kb.


Key words:

Bronchopulmonary dysplasia, preterm newborn, risk factors.

ABSTRACT

Background: Bronchopulmonary dysplasia (BPD) is a chronic lung disease that depends on supplementary treatment with oxygen at 28 days of life. Mechanical ventilation is the main risk factor to develop this pathology. Objective: Identify the frequency of the most common risk factors associated with BPD in patients with such diagnostic. Methods: This study was observational, retrospective and descriptive. Data was collected from medical records with BPD diagnostic from General Hospital “Dr. Manuel Gea González” between January 2009 to December 2014. 69 patients were sampled. Different variables were analyzed with descriptive statistics. Results: 60.9% were males, 15.9% used prenatal steroid therapy, mean gestational age was 32.8 ± 2.3 weeks, weight birth 1,438.1 ± 559.9 g, 94.2% required mechanical ventilation with an average of 18.2 days. The most frequent comorbidities were sepsis or pneumonia, anemia, retinopathy of prematurity and intraventricular hemorrhage. Conclusions: In this study we found the most frequently associated risk factors to BPD being the prematurity related the most common of them all.


REFERENCES

  1. Kinsella PJ, Greenough A, Abman, SH. Bronchopulmonary dysplasia. Lancet. 2006; 367: 1421-1431.

  2. Northway WH Jr., Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967; 276: 357-368.

  3. Jobe AH, Bancalari E. NICHD/NHLBI/ORD workshop summary: bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001; 163: 1723-1729.

  4. Gien J, Kinsella J. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr. 2011; 23(3): 305-313.

  5. Jansen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Research (Part A). 2014; 100: 145-157.

  6. Bhandari V. Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014; 100(3): 189-201.

  7. Wright CJ, Kirpalani H. Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies? Pediatrics. 2011; 128(1): 111-126.

  8. Ghanta S, Tropea K, Christou H. An update on pharmacologic approaches to bronchopulmonary dysplasia. Semin Perinatol. 2013; 37(2): 115-123.

  9. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH et al. Validation of the National Institutes of Health Consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005; 116: 1353-1360.

  10. Farstad T, Bratild D, Medbo S, Markestad T et al. Bronchopulmonary dysplasia- prevalence, severity and predictive factors in a national cohort of extremely premature infants. Acta Paediatrica. 2011; 100: 53-38.

  11. Lapcharoensap W, Gage SC, Kan P, Profit J et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr. 2015; 169(2): e143676.

  12. Landry JS, Chan T, Lands L, Menzies D. Ocurrence and severity of bronchopulmonary dysplasia and respiratory distress syndrome after a preterm birth. Can Respir J. 2011:18(5)265-270.

  13. Klinger G, Skolover N, Boyko V, Sirota L et al. Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-low-birthweight infants. Am J Obstet Gynecol. 2013; 208: 115e1-9.

  14. Cunha GS, Mezzacappa-Filho F, Ribeiro J. Risk factors for bronchopulmonary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life. J Trop Pediatr. 2005; 51(6): 334-340.

  15. Shima, Y, Kumasaka S, Migita M. Perinatal risk factors for adverse long-term pulmonary outcome in premature infants: comparison of different definitions of bronchopulmonary dysplasia/chronic lung disease. Pediatrics International. 2013; 55: 578-581.

  16. Li Yanhong, Yan J, Li M, Xiao Z et al. Addition of SNAP to perinatal risk factors improves the prediction of bronchopulmonary dysplasia or death in critically ill preterm infants. BMC Pediatrics. 2013; 13: 138.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2015;82